. Author manuscript; available in PMC: 2023 Jul 28.

Published in final edited form as: Plast Reconstr Surg. 2022 Jul 27;150(2):446–455. doi: 10.1097/PRS.0000000000009334

Table 4:

Patient Comorbidities Associated with Neuropathic Pain

	Neuropathic pain		p
	Yes (n=584, 37%)	No (n=981, 63%)
Elixhauser comorbidity score, median (IQR)	6 (4–10)	7 (4–10)	0.022^*
Diabetes mellitus, n(%)	273 (31)	615 (69)	<0.001^*
Hypertension, n(%)	397 (36)	705 (64)	0.11
Cardiac disease, n(%)	381 (35)	710 (65)	0.003^*
Chronic pulmonary disease, n(%)	145 (40)	222 (61)	0.32
Obesity, n(%)	95 (40)	144 (60)	0.42
Tobacco use, n(%)	187 (42)	257 (58)	0.015^*
Alcohol abuse, n(%)	17 (34)	33 (66)	0.66
Drug abuse, n(%)	83 (49)	86 (51)	0.001^*
History of psychiatric disease, n(%)	259 (46)	302 (54)	<0.001^*
Hypothyroidism, n(%)	135 (33)	276 (67)	0.032^*
Rheumatoid arthritis/collagen vascular diseases, n(%)	82 (37)	142 (63)	0.88
Paralysis, n(%)	17 (30)	39 (70)	0.33
Neurodegenerative disorders, n(%)	45 (34)	86 (66)	0.51
Liver disease, n(%)	64 (40)	98 (61)	0.55

IQR, interquartile range.

Statistically significant.